Search Results for 'nsclc'

nsclc published presentations and documents on DocSlides.

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

by everly

Professor Rachel Butler. The genomic complexity of...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

by debby-jeon

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Antiangiogenic Agents in Advanced NSCLC

Antiangiogenic Agents in Advanced NSCLC

by ellena-manuel

Jared Weiss, MD . Assistant . Professor of Medici...

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

by stefany-barnette

Renato G. Martins, MD, MPH. Medical Director, Tho...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

by sawyer742

Intervista a Federico . Cappuzzo. Background:. Pr...

by cheryl-pisano

Le Chevalier, . MD. The Role of Translational Res...

by alida-meadow

Gandara. , MD. University of California, Davis . ...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

by debby-jeon

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

by luanne-stotts

Brada. . Torino. . 6 March 2015. Perspectives...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

by ellena-manuel

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

by test

Intervista a Federico . Cappuzzo. Background:. P...

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

by jane-oiler

of the expression of . 17-beta-hydroxysteroid . ...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

by pasty-toler

This program will include a discussion of off-lab...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

by stefany-barnette

The Cancer genome atlas (TCGA) and the search for...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC

by southan

Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

by scarlett

NSCLC, non-small cell lung cancer.. Lung cancer in...

Beth Sandy, MSN, CRNP Nurse Practitioner

Beth Sandy, MSN, CRNP Nurse Practitioner

by PriceOfFreedom

Abramson Cancer Center . University of Pennsylvani...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

by elena

Kamil Konopka. Department of Oncology, University ...

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer

by oconnor

. 5. th. most commonly diagnosed cancer in Austra...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

Consensus or Controversy?

Consensus or Controversy?

by okelly

Addressing Practical Clinical Questions Across the...

L’algoritmo terapeutico

L’algoritmo terapeutico

by calandra-battersby

attraverso . i . c. asi clinici. Giuseppe . Valma...

NSCLC: Staging and TNM classification

NSCLC: Staging and TNM classification

by molly

NSCLC, non-small cell lung cancer; TNM. , tumour, ...

Estimated costs of managing treatment-related adverse

Estimated costs of managing treatment-related adverse

by lindy-dunigan

eventsof. . nivolumab. and . docetaxel. in the...

OMICS International welcomes submissions that are original and technically so as to serve both th

OMICS International welcomes submissions that are original and technically so as to serve both th

by lois-ondreau

OMICS Journals are poised in excellence by publi...

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

by olivia-moreira

Low TPS High TPS TPS = PD-L1 tumor proportion sco...

ASCO 2019 NSCLC - PARP & Chemotherapy

ASCO 2019 NSCLC - PARP & Chemotherapy

by mitsue-stanley

ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...

Lung cancer Treatment

Lung cancer Treatment

by attentionallianz

Consequences of the Lack of Patients of color &...

Module 13: Targeted Treatment

Module 13: Targeted Treatment

by disclaimercanon

of Lung Cancer . Wendi S Lee, MSN, RN, NP-C. Anne ...

Please note, these are the

Please note, these are the

by vizettan

actual. . video-recorded proceedings from the . l...

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

by singh

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

Presented at the European Society for Medical Oncology 2019 Barcelona

Presented at the European Society for Medical Oncology 2019 Barcelona

by lucy

– 1 October, 2019 ● GSK 3377794 activate and i...

Instructions for Use of These Slides

Instructions for Use of These Slides

by carla

The purpose of these slides is to serve as a resou...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

by cheryl-pisano

Giorgio V. Scagliotti. University. of . Torino,....

Minesh Mehta, Northwestern University

Minesh Mehta, Northwestern University

by mitsue-stanley

Chicago, IL. Radiation for Prevention and Treatme...

Italian cohort of

Italian cohort of

by test

nivolumab. Expanded Access . Programme. (EAP): ...